Cannabis Reclassification Would Expand Banking Access to Industry, Advocate Says
Introduction The ongoing discussion surrounding cannabis reclassification has garnered significant attention due to its potential impact on the industry. Currently, cannabis is classified as a Schedule I drug by the Drug Enforcement Administration (DEA), placing it alongside substances like heroin and illicit fentanyl. This classification denotes a high potential for abuse and no accepted medical …